148 related articles for article (PubMed ID: 26343139)
1. Oleanolic Acid A-lactams Inhibit the Growth of HeLa, KB, MCF-7 and Hep-G2 Cancer Cell Lines at Micromolar Concentrations.
Bednarczyk-Cwynar B; Ruszkowski P; Bobkiewicz-Kozlowska T; Zaprutko L
Anticancer Agents Med Chem; 2016; 16(5):579-92. PubMed ID: 26343139
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and cytotoxicity evaluation of oleanolic acid derivatives.
Hao J; Liu J; Wen X; Sun H
Bioorg Med Chem Lett; 2013 Apr; 23(7):2074-7. PubMed ID: 23434227
[TBL] [Abstract][Full Text] [Related]
3. Anticancer effect of A-ring or/and C-ring modified oleanolic acid derivatives on KB, MCF-7 and HeLa cell lines.
Bednarczyk-Cwynar B; Zaprutko L; Ruszkowski P; Hładoń B
Org Biomol Chem; 2012 Mar; 10(11):2201-5. PubMed ID: 22222767
[TBL] [Abstract][Full Text] [Related]
4. Synthesis of novel oleanolic acid and ursolic acid in C-28 position derivatives as potential anticancer agents.
Tian T; Liu X; Lee ES; Sun J; Feng Z; Zhao L; Zhao C
Arch Pharm Res; 2017 Apr; 40(4):458-468. PubMed ID: 28101738
[TBL] [Abstract][Full Text] [Related]
5. Synthesis of oleanolic acid dimers linked at C-28 and evaluation of anti-tumor activity.
Cheng KG; Su CH; Yang LD; Liu J; Chen ZF
Eur J Med Chem; 2015 Jan; 89():480-9. PubMed ID: 25462260
[TBL] [Abstract][Full Text] [Related]
6. Design and preparation of derivatives of oleanolic and glycyrrhetinic acids with cytotoxic properties.
Wang R; Li Y; Huai XD; Zheng QX; Wang W; Li HJ; Huai QY
Drug Des Devel Ther; 2018; 12():1321-1336. PubMed ID: 29861624
[TBL] [Abstract][Full Text] [Related]
7. Design and synthesis of the novel oleanolic acid-cinnamic acid ester derivatives and glycyrrhetinic acid-cinnamic acid ester derivatives with cytotoxic properties.
Wang R; Yang W; Fan Y; Dehaen W; Li Y; Li H; Wang W; Zheng Q; Huai Q
Bioorg Chem; 2019 Jul; 88():102951. PubMed ID: 31054427
[TBL] [Abstract][Full Text] [Related]
8. Synthesis of ring-C modified oleanolic acid derivatives and their cytotoxic evaluation.
Pattnaik B; Lakshma Nayak V; Ramakrishna S; Venkata Mallavadhani U
Bioorg Chem; 2016 Oct; 68():152-8. PubMed ID: 27522460
[TBL] [Abstract][Full Text] [Related]
9. Design and Synthesis of New Anticancer Glycyrrhetinic Acids and Oleanolic Acids.
Wang R; Zheng QX; Wang W; Feng L; Li HJ; Huai QY
Biol Pharm Bull; 2017; 40(5):703-710. PubMed ID: 28458357
[TBL] [Abstract][Full Text] [Related]
10. Hederagenin as a triterpene template for the development of new antitumor compounds.
Rodríguez-Hernández D; Demuner AJ; Barbosa LC; Csuk R; Heller L
Eur J Med Chem; 2015 Nov; 105():57-62. PubMed ID: 26476750
[TBL] [Abstract][Full Text] [Related]
11. [Synthesis and anti-tumor activity of oleanolic acid derivatives].
Meng YQ; Nie HH; Wang XC; Li D; Ge CX; Zhao N; Chen H; Cao B
Yao Xue Xue Bao; 2011 Oct; 46(10):1215-20. PubMed ID: 22242453
[TBL] [Abstract][Full Text] [Related]
12. Nitrogen-containing ecdysteroid derivatives vs. multi-drug resistance in cancer: Preparation and antitumor activity of oximes, oxime ethers and a lactam.
Vágvölgyi M; Martins A; Kulmány Á; Zupkó I; Gáti T; Simon A; Tóth G; Hunyadi A
Eur J Med Chem; 2018 Jan; 144():730-739. PubMed ID: 29291440
[TBL] [Abstract][Full Text] [Related]
13. Enhancing anticancer activity through the combination of bioreducing agents and triterpenes.
Bednarczyk-Cwynar B; Ruszkowski P; Jarosz T; Krukiewicz K
Future Med Chem; 2018 Mar; 10(5):511-525. PubMed ID: 29424550
[TBL] [Abstract][Full Text] [Related]
14. HYBRIDS OF OLEANOLIC ACID WITH NORBORNENE-2,3-DICARBOXIMIDE-N- CARBOXYLIC ACIDS AS POTENTIAL ANTICANCER AGENTS.
Bednarczyk-Cwynar B; Ruszkowskp P; Atamanyuk D; Lesyk R; Zaprutko L
Acta Pol Pharm; 2017 May; 74(3):827-835. PubMed ID: 29513952
[TBL] [Abstract][Full Text] [Related]
15. Design, synthesis, and antitumor activity of oleanolic acid derivatives.
Meng YQ; Kuai ZY; Zhan SW; Li CL; Chen HR
J Asian Nat Prod Res; 2019 Jul; 21(7):633-651. PubMed ID: 29733221
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and antitumor activities of naturally occurring oleanolic acid triterpenoid saponins and their derivatives.
Liu Q; Liu H; Zhang L; Guo T; Wang P; Geng M; Li Y
Eur J Med Chem; 2013 Jun; 64():1-15. PubMed ID: 23639650
[TBL] [Abstract][Full Text] [Related]
17. Synthesis of novel heterocyclic oleanolic acid derivatives with improved antiproliferative activity in solid tumor cells.
Leal AS; Wang R; Salvador JA; Jing Y
Org Biomol Chem; 2013 Feb; 11(10):1726-38. PubMed ID: 23381885
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and antitumor activity evaluation of novel oleanolic acid derivatives.
Meng YQ; Zhao YW; Kuai ZY; Liu LW; Li W
J Asian Nat Prod Res; 2017 Oct; 19(10):1000-1010. PubMed ID: 28140665
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and tumor cytotoxicity of novel amide derivatives of β-hederin.
Liu Y; Lu WX; Yan MC; Yu Y; Ikejima T; Cheng MS
Molecules; 2010 Nov; 15(11):7871-83. PubMed ID: 21060295
[TBL] [Abstract][Full Text] [Related]
20. Conjugation of Uridine with Oleanolic Acid Derivatives as Potential Antitumor Agents.
Cheng KG; Su CH; Huang JY; Liu J; Zheng YT; Chen ZF
Chem Biol Drug Des; 2016 Sep; 88(3):329-40. PubMed ID: 26990000
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
